Rolipram Completed Phase 2 Trials for Disseminated Sclerosis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00011375Rolipram to Treat Multiple Sclerosis